NCT05980455View on ClinicalTrials.gov

Study of Enterra Programming with Nocturnal Cycling in Gastroparetics

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
GastroparesisGastroparesis NondiabeticGastroparesis Due to Diabetes Mellitus
Interventions
DEVICE

Enterra® Therapy System

The Enterra® Therapy System for gastric electrical stimulation (GES) is indicated for the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years.

Trial Locations (2)

40202

RECRUITING

University of Louisville, Louisville

55433

RECRUITING

MNGI Digestive Health, P.A., Coon Rapids

Sponsors
All Listed Sponsors
lead

Enterra Medical, Inc.

INDUSTRY

NCT05980455 - Study of Enterra Programming with Nocturnal Cycling in Gastroparetics | Biotech Hunter | Biotech Hunter